The Senior Fellowship scheme, which was launched in 2019, recognises and supports mid-career individuals with the potential and trajectory to become future leaders in translational research in the NIHR in Oxford.
Fellows will receive an award of £5,000 a year for two years that can be used flexibly to facilitate their translational research programme and career development, for example on travel costs for research activities, attending conferences or career development and leadership training.
They will also attend a leadership programme, which is being facilitated by Milly Sinclair Associates, who organised a Women in Leadership training course for the Oxford BRC’s Cardiovascular Theme.
Dr Sarah Gooding, Cancer Research UK Clinician Scientist at the MRC WIMM, was one of the successful applicants this year. Sarah’s research is focused on the genetics and biology of the highest-risk cases of the incurable bone marrow cancer multiple myeloma and finding better ways to identify and treat it.
Dr Gooding said:
I am delighted to be chosen for this fellowship. It is a brilliant validation of exciting collaborative work done with Oxford University Hospitals, NIHR Oxford BRC and Oxford Translational Myeloma Centre to incorporate genetic sequencing into a mainstream NHS approach to risk-adapted treatment for the incurable blood cancer Multiple Myeloma.
For me personally, the leadership coaching it supports will be invaluable at this stage of my career.